CING Straddle Strategy
CING (Cingulate Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.
CING (Cingulate Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $27.6M, a beta of -0.81 versus the broader market, a 52-week range of 3.2-11.89, average daily share volume of 515K, a public-listing history dating back to 2021, approximately 13 full-time employees. These structural characteristics shape how CING stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.81 indicates CING has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a straddle on CING?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current CING snapshot
As of May 15, 2026, spot at $4.59, ATM IV 229.80%, expected move 65.88%. The straddle on CING below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on CING specifically: IV rank is unavailable in the current snapshot, so regime-based timing for CING is inferred from ATM IV at 229.80% alone, with a market-implied 1-standard-deviation move of approximately 65.88% (roughly $3.02 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CING expiries trade a higher absolute premium for lower per-day decay. Position sizing on CING should anchor to the underlying notional of $4.59 per share and to the trader's directional view on CING stock.
CING straddle setup
The CING straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CING near $4.59, the first option leg uses a $4.59 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CING chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CING shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $4.59 | N/A |
| Buy 1 | Put | $4.59 | N/A |
CING straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
CING straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on CING. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on CING
Straddles on CING are pure-volatility plays that profit from large moves in either direction; traders typically buy CING straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
CING thesis for this straddle
The market-implied 1-standard-deviation range for CING extends from approximately $1.57 on the downside to $7.61 on the upside. A CING long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. As a Healthcare name, CING options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CING-specific events.
CING straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CING positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CING alongside the broader basket even when CING-specific fundamentals are unchanged. Always rebuild the position from current CING chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on CING?
- A straddle on CING is the straddle strategy applied to CING (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With CING stock trading near $4.59, the strikes shown on this page are snapped to the nearest listed CING chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CING straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the CING straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 229.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CING straddle?
- The breakeven for the CING straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CING market-implied 1-standard-deviation expected move is approximately 65.88%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on CING?
- Straddles on CING are pure-volatility plays that profit from large moves in either direction; traders typically buy CING straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current CING implied volatility affect this straddle?
- Current CING ATM IV is 229.80%; IV rank context is unavailable in the current snapshot.